At Statistical Outsourcing Service, we understand both the statistical aspects and the
art of business. From development to post marketing, Statistical Outsourcing Services gives you the insight you
need to achieve compliance and operating efficiency, so you can cut costs and boost revenue.
· Experience applying advanced analytical solutions
to business problems including linear and nonlinear modeling, sampling and experimental design.
· Expertise in working
on process improvement efforts including Six Sigma.
·
Project and client management.
·
Develop customized statistical training for different audience levels.
Professional experience
2005-Present
Statistical Outsourcing Services, President
· LONZA
· Lonza
is a contract manufacturer for biological products.
·
Provided consultation on process validation for fermentation and purification processes.
·
DELMARVA
· Reviewed
and analyzed patient care survey data leading to program improvements and improved overall patient care.
· Developed Return
on Investment and Business Case documentation for Quality Improvement in a hospital setting.
·
ORIZON
· Orizon
is am Information Technology (IT) firm that develops data warehouse and business analytics applications for different branches
of the US government.
·
Using SAS 9.0, developed an Extraction, Transformation and Loading (ETL) algorithm for a Business Intelligence (BI)
application used in the mortgage industry.
· STRYKER
· Stryker Biotech is
developing a biological product for healing bone after surgery.
·
Reviewed current “as-is” strategy for process validation. Developed a new process for statistically
analyzing process data to improve the report writing process.
· AGENNIX
· Agennix
is a small biotech firm that is in Phase II development.
·
Developed statistical analysis of bioassay data for method validation
· HGS
· Human
Genome Sciences (HGS) is a biotech firm that is in Phase III development.
· Developed statistical analysis of bioassay data
for method validation
·
PTi
· PTi
is a leading provider of training for the pharmaceutical and biotech industry.
· Developed and presented on-site courses introductory
statistics and regression analysis.
2001-2005 Human Genome Sciences, Senior Manager, Non-clinical Statistics
·
Nonlinear models for assay development.
·
Immunogenicity analysis.
·
Method validation.
·
Responsible for hiring and managing direct reports.
1998-2001
PricewaterhouseCoopers LLP, Senior Associate
· Integrated
a LIMS system into an Enterprise Resource Planning (ERP) system.
· Customer Relationship Management (CRM) analysis
for telecom company.
·
Market share analysis for pharmaceuticals using IMS database.
· Litigation support.
1993-1998 Chiron
Diagnostics, Statistical Methods Manager
· Implementation
of statistical methods in research, product development and manufacturing environments.
· Validation of next generation
chemiluminescence instrument.
·
Assay qualification.
1991-1993
Ethicon Inc., a Johnson & Johnson Company, Quality Engineer/Biostatistician
· Responsible for design
and analysis of clinical studies for adhesion prevention.
·
Led marketing studies for comparing competitor products based on in-vivo studies.
· Implemented statistical experimentation
in process qualification and improvement.
1989-1991 Degussa Corporation, Quality Manager
1988-1989 IIT Research Institute, Statistician
Education
Executive
Masters of Business Administration (with Honors), May 1998
BOSTON
UNIVERSITY, Boston, Massachusetts
Masters
of Science in Statistics, May 1992
RUTGERS UNIVERSITY, New
Brunswick, New Jersey
Bachelor
of Arts in Statistics, May 1987
STATE UNIVERSITY OF NEW YORK
AT BUFFALO, Buffalo, New York
Software applications
SAS, JMP, Minitab, R and S-Plus
Publications
· S. Walfish,
“Statistically Rational Sampling Plans for Audits” The Auditor December
2007
· S.
Walfish, “A Statistical Perspective on the ICH Q2A and Q2B Guidelines for Validation of Analytical Methods”
BioPharm19(12) 28-37 (2006)
·
S. Walfish, “A Review of Statistical Outlier Methods” Pharmaceutical Technology 30(11)
82-88 (2006)
· S.
Walfish, “Statisticians Tackle More Than Clinical Trials” BioPharm 19(2) 44-45 (2006)
· Optimization
of animal-component-free medium for CHO cell growth and recombinant protein production using statistical design. R. Bhatia,
C. Robberson, T. Osborne, S. Walfish, J. Zhang, 225th ACS National Meeting.
· J. D. Williams, J. B. Birch
and S. Walfish, “A Statistical Method to Account for Plate-to-Plate Variability in Multiple-Plate Bioassays,”
BioPharm16(5) 66 (2003)
Presentations
·
A Case Study in Process Characterization Experimental Budget, BioProcess International Conference Oct 2007
· Data Analysis, Deciding
What's Important and What's Not, MD&M Minneapolis
·
Statistically Rational Sampling Plans for Audits, 2007 ASQ Audit Division Conference
· Monitoring and Measuring Quality
System Performance through Quality, Regulatory and Compliance Metrics, MD&M New York
· Process Capability Analysis
and Setting Data Driven Specifications, Biopharm Webinar Series
·
Statistical Analysis Methods for Environmental Monitoring and Water Testing Programs, Biopharm Webinar Series
· Applying
Statistics Recommended by Regulatory Documents, 2006 Method Validation Conference, Institute for Validation Technology
· Tackling
Statistical Uncertainty in Method Validation, 2006 Method Validation Conference, Institute for Validation Technology
· Lies,
Damn Lies and Statistics; Understanding your Statistical Assumptions, 2006 Out of Specification Conference, Institute for
Validation Technology
·
How Far is too Far? Statistical Outlier Detection, 2006 Out of Specification Conference, Institute for Validation
Technology
· Using
Statistical Methods in Stability Testing, 2004 CBI Research 6th Annual Stability Testing Forum
· Using Statistical
Tools for Process Validation, 2003 Barnett International Process Validation for Biopharmaceutical Manufacturing
· Statistical Approaches
to Process Validation, 2003 IBC Conference on Process Validation in Biologics
· Optimizing Shipping Times Using Fractional Factorials,
2002 American Statistical Association, Quality and Productivity Research Conference.
· Selling Pharmaceuticals in China, Capstone Project
1998 Executive MBA
·
Determining Reference Ranges, 1997 AACC Meeting
·
Statistics Primer: When is zero zero?, May 1996 NELRAD Annual Meeting
Professional Memberships
·
American Society of Quality
·
Certified Quality Engineer (CQE)
·
Biomedical Division Treasurer (2004-2005)
·
Biomedical Division Chair-elect (2005-2006)
·
Biomedical Division Chair (2006-2007)
·
Member of the Editorial Advisory Board for BioPharm magazine